Speaker illustration

Mrs Renske Olie

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

Comparison of three different platelet function tests in patients on P2Y12 inhibitors in correlation to genetic background.

Event: ESC Congress 2018

Topic: Pharmacogenetics

Session: Pharmacogenetics - New sights on the horizon


Effects of the PAR-1 receptor antagonist vorapaxar on platelet activation and coagulation biomarkers in patients with stable coronary artery disease

Event: ESC Congress 2018

Topic: Antiplatelet Drugs

Session: Innovative drug therapies


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb